676 related articles for article (PubMed ID: 20543672)
21. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients.
Goldberg A; Confino-Cohen R; Mekori YA
Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057
[TBL] [Abstract][Full Text] [Related]
22. Component Resolved Diagnosis in Hymenoptera Anaphylaxis.
Tomsitz D; Brockow K
Curr Allergy Asthma Rep; 2017 Jun; 17(6):38. PubMed ID: 28501976
[TBL] [Abstract][Full Text] [Related]
23. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
van der Brempt X; Ledent C; Mairesse M
Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
[TBL] [Abstract][Full Text] [Related]
24. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
25. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
26. Venom immunotherapy for preventing allergic reactions to insect stings.
Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
[TBL] [Abstract][Full Text] [Related]
27. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
[TBL] [Abstract][Full Text] [Related]
29. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome after venom immunotherapy.
Golden DB
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):337-41. PubMed ID: 20610978
[TBL] [Abstract][Full Text] [Related]
31. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
[TBL] [Abstract][Full Text] [Related]
32. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
[TBL] [Abstract][Full Text] [Related]
33. Hymenoptera venom allergy.
Ebo DG
Verh K Acad Geneeskd Belg; 2007; 69(4):213-30. PubMed ID: 17821959
[TBL] [Abstract][Full Text] [Related]
34. New directions in diagnostic evaluation of insect allergy.
Golden DB
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):334-9. PubMed ID: 24915545
[TBL] [Abstract][Full Text] [Related]
35. Allergy to bumblebee venom.
Bucher C; Korner P; Wüthrich B
Curr Opin Allergy Clin Immunol; 2001 Aug; 1(4):361-5. PubMed ID: 11964714
[TBL] [Abstract][Full Text] [Related]
36. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
[No Abstract] [Full Text] [Related]
37. Double (honeybee and wasp) immunoglobulin E reactivity in patients allergic to Hymenoptera venom: the role of cross-reactive carbohydrates and alcohol consumption.
Carballada FJ; González-Quintela A; Núñez-Orjales R; Vizcaino L; Boquete M
J Investig Allergol Clin Immunol; 2010; 20(6):484-9. PubMed ID: 21243932
[TBL] [Abstract][Full Text] [Related]
38. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
Goldberg A; Yogev A; Confino-Cohen R
Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of allergies to Hymenoptera venom].
Charpin J; Vervloet D; Birnbaum J
Bull Acad Natl Med; 1982 Apr; 166(4):539-44. PubMed ID: 6751497
[No Abstract] [Full Text] [Related]
40. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients.
Lerch E; Müller UR
J Allergy Clin Immunol; 1998 May; 101(5):606-12. PubMed ID: 9600496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
